Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

被引:28
作者
Wu Qi [1 ]
Chen Gang-Ling [2 ]
Li Ya-Juan [3 ]
Chen Yang [2 ]
Lin Fang-Zhen [2 ]
机构
[1] China Pharmaceut Univ, Res Dept Pharmacognosy, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm Chinese Mat Med, Nanjing 211198, Jiangsu, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Murad Res Inst Modernized Chinese Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeoniflorin; Lung cancer; Metastasis; Alternatively activated macrophages; Tumor-associated macrophages; TUMOR; LYMPHANGIOGENESIS; ACTIVATION;
D O I
10.1016/S1875-5364(15)30098-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 mu mol.L-1, P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 mu mol.L-1, P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by]L-4 (paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg.kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [41] miR-338 inhibits the metastasis of lung cancer by targeting integrin 3
    Chen, Xiao
    Wei, Li
    Zhao, Song
    ONCOLOGY REPORTS, 2016, 36 (03) : 1467 - 1474
  • [42] Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity
    Zhao, Pengfei
    Zhang, Jiaxin
    Wu, Aihua
    Zhang, Meng
    Zhao, Yuge
    Tang, Yisi
    Wang, Bing
    Chen, Tianxiang
    Li, Feng
    Zhao, Qiang
    Huang, Yongzhuo
    JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 1249 - 1261
  • [43] Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
    Hallett, Robin M.
    Bonfill-Teixidor, Ester
    Iurlaro, Raffaella
    Arias, Alexandra
    Raman, Swetha
    Bayliss, Peter
    Egorova, Olga
    Neva-Alejo, Almudena
    McGray, A. J. Robert
    Lau, Esther
    Bosch, Alexandre
    Beilschmidt, Melissa
    Maetzel, Dorothea
    Fransson, Johan
    Huber-Ruano, Isabel
    Anido, Judit
    Julien, Jean-Philippe
    Giblin, Patricia
    Seoane, Joan
    CLINICAL CANCER RESEARCH, 2023, 29 (04) : 791 - 804
  • [44] Cytochalasin B Modulates Macrophage-Mediated Inflammatory Responses
    Kim, Mi-Yeon
    Kim, Jong-Hoon
    Cho, Jae Youl
    BIOMOLECULES & THERAPEUTICS, 2014, 22 (04) : 295 - 300
  • [45] Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells
    Bian, Yuan
    Li, Qiu
    Li, Qiaolian
    Pan, Ruigen
    MOLECULAR MEDICINE REPORTS, 2020, 22 (03) : 1767 - 1774
  • [46] Shedding light on macrophage immunotherapy in lung cancer
    Ma, Huiyun
    Zhang, Zhouwei
    Hu, Qin
    Chen, Hongyu
    Wu, Gujie
    Zhou, Youlang
    Xue, Qun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 8143 - 8152
  • [47] Immunoglobulin-Like Transcript 5 Inhibits Macrophage-Mediated Bacterial Killing and Antigen Presentation During Sepsis
    Ming, Siqi
    Li, Musheng
    Wu, Minhao
    Zhang, Jianhui
    Zhong, Haibo
    Chen, Junyang
    Huang, Yaopan
    Bai, Jun
    Huang, Li
    Chen, Juan
    Lin, Quanshi
    Liu, Jiao
    Tao, Jianping
    He, Duanman
    Huang, Xi
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (10) : 1688 - 1699
  • [48] Metastasis of lung cancer?
    Qi Kang
    Liu Haibo
    Lin Gang
    Hu Yanyan
    Nong Lin
    Zhang Janhua
    Wang Bing
    Li Jian
    ACTA CHIRURGICA BELGICA, 2023, 123 (03) : 313 - 316
  • [49] Leveraging Macrophage-Mediated Cancer Immunotherapy via a Cascading Effect Induced by a Molecularly Imprinted Nanocoordinator
    Xu, Shuxin
    Gu, Zikuan
    Lu, Haifeng
    Guan, Peixin
    Liu, Zhen
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (23) : 27658 - 27669
  • [50] Regulatory Effect of Cinnamaldehyde on Monocyte/Macrophage-Mediated Inflammatory Responses
    Kim, Byung Hun
    Lee, Yong Gyu
    Lee, Jaehwi
    Lee, Joo Young
    Cho, Jae Youl
    MEDIATORS OF INFLAMMATION, 2010, 2010